Big Pharma bets on AI to speed up clinical trials
By Natalie Grover and Martin Coulter LONDON (Reuters) – Major drugmakers are using artificial intelligence...
By Natalie Grover and Martin Coulter LONDON (Reuters) – Major drugmakers are using artificial intelligence...
(Reuters) -Billionaire entrepreneur Elon Musk’s brain-chip startup Neuralink said on Tuesday it has received approval...
(Reuters) – GE HealthCare Technologies Inc has received a grant of more than $44 million...
(Reuters) -Johnson & Johnson on Wednesday forecast double-digit profit growth for 2023 after spinning off...
(Reuters) – The U.S. government said on Tuesday it had awarded $1.4 billion for the...
(Reuters) -Gilead Sciences said on Monday the U.S. health regulator placed a clinical hold on...
By Michael Erman (Reuters) -Gilead Sciences on Thursday reported lower second-quarter profit as costs from...
By Leroy Leo and Patrick Wingrove (Reuters) -AbbVie on Thursday trimmed its 2023 view for...
By Bhanvi Satija and Patrick Wingrove (Reuters) -Johnson & Johnson on Thursday expressed optimism for...
By Brendan Pierson (Reuters) – Lawyers for a California man who says he developed a...